BlackRock’s Medtronic MDT Stock Holding History

BlackRock’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.81B	Sell	113,182,567 -7,355,311	-6%	-$705M	0.17%	97
2025 Q4	$11.6B	Buy	120,537,878 +969,072	+0.8%	+$94.1M	0.2%	88
2025 Q3	$11.4B	Sell	119,568,806 -2,880,535	-2%	-$265M	0.2%	84
2025 Q2	$10.7B	Buy	122,449,341 +5,092,931	+4%	+$432M	0.2%	80
2025 Q1	$10.5B	Buy	117,356,410 +3,183,599	+3%	+$285M	0.22%	78
2024 Q4	$9.12B	Buy	114,172,811 +2,914,729	+3%	+$252M	0.18%	85
2024 Q3	$10B	Sell	111,258,082 -634,296	-0.6%	-$53.4M	0.21%	79
2024 Q2	$8.81B	Sell	111,892,378 -2,088,286	-2%	-$171M	0.2%	85
2024 Q1	$9.93B	Sell	113,980,664 -4,592,524	-4%	-$392M	0.23%	69
2023 Q4	$9.77B	Buy	118,573,188 +3,025,839	+3%	+$231M	0.25%	63
2023 Q3	$9.05B	Buy	115,547,349 +595,824	+0.5%	+$49.9M	0.26%	59
2023 Q2	$10.1B	Sell	114,951,525 -2,735,131	-2%	-$235M	0.28%	58
2023 Q1	$9.49B	Sell	117,686,656 -4,604,295	-4%	-$375M	0.28%	61
2022 Q4	$9.5B	Buy	122,290,951 +6,292,390	+5%	+$510M	0.3%	57
2022 Q3	$9.37B	Buy	115,998,561 +5,620,477	+5%	+$505M	0.32%	49
2022 Q2	$9.91B	Buy	110,378,084 +2,386,432	+2%	+$242M	0.32%	52
2022 Q1	$12B	Buy	107,991,652 +88,290	+0.1%	+$9.33M	0.32%	54
2021 Q4	$11.2B	Buy	107,903,362 +4,883,180	+5%	+$565M	0.28%	59
2021 Q3	$12.9B	Sell	103,020,182 -1,596,127	-2%	-$207M	0.36%	48
2021 Q2	$13B	Sell	104,616,309 -2,138,321	-2%	-$268M	0.36%	45
2021 Q1	$12.6B	Sell	106,754,630 -353,130	-0.3%	-$41.4M	0.37%	43
2020 Q4	$12.5B	Sell	107,107,760 -5,059,424	-5%	-$557M	0.4%	41
2020 Q3	$11.7B	Buy	112,167,184 +957,298	+0.9%	+$96.1M	0.43%	40
2020 Q2	$10.2B	Buy	111,209,886 +4,352,426	+4%	+$417M	0.41%	42
2020 Q1	$9.64B	Sell	106,857,460 -2,704,461	-2%	-$288M	0.47%	35
2019 Q4	$12.4B	Buy	109,561,921 +4,643,503	+4%	+$510M	0.48%	32
2019 Q3	$11.4B	Sell	104,918,418 -2,272,693	-2%	-$237M	0.48%	32
2019 Q2	$10.4B	Buy	107,191,111 +413,027	+0.4%	+$37.7M	0.45%	35
2019 Q1	$9.73B	Buy	106,778,084 +7,856,946	+8%	+$703M	0.43%	35
2018 Q4	$9B	Buy	98,921,138 +1,487,997	+2%	+$139M	0.45%	32
2018 Q3	$9.58B	Sell	97,433,141 -434,526	-0.4%	-$40.2M	0.41%	37
2018 Q2	$8.38B	Buy	97,867,667 +1,966,789	+2%	+$164M	0.39%	39
2018 Q1	$7.69B	Buy	95,900,878 +1,305,298	+1%	+$108M	0.37%	46
2017 Q4	$7.64B	Buy	94,595,580 +5,688,180	+6%	+$456M	0.36%	44
2017 Q3	$6.91B	Sell	88,907,400 -604,829	-0.7%	-$50.2M	0.35%	47
2017 Q2	$7.94B	Buy	89,512,229 +2,476,853	+3%	+$209M	0.42%	38
2017 Q1	$7.01B	Buy	87,035,376 +83,705,052	+2,513%	+$6.54B	0.38%	37
2016 Q4	$237M	Sell	3,330,324 -75,045	-2%	-$5.9M	0.34%	52
2016 Q3	$294M	Buy	3,405,369 +18,342	+0.5%	+$1.6M	0.42%	42
2016 Q2	$294M	Buy	3,387,027 +244,084	+8%	+$19.7M	0.44%	41
2016 Q1	$236M	Sell	3,142,943 -750,546	-19%	-$56.5M	0.38%	52
2015 Q4	$299M	Sell	3,893,489 -177,046	-4%	-$13.3M	0.44%	46
2015 Q3	$272M	Buy	4,070,535 +77,861	+2%	+$5.73M	0.43%	48
2015 Q2	$296M	Sell	3,992,674 -121,530	-3%	-$9.29M	0.44%	49
2015 Q1	$321M	Buy	4,114,204 +1,348,945	+49%	+$102M	0.44%	55
2014 Q4	$200M	Buy	2,765,259 +64,866	+2%	+$4.51M	0.29%	76
2014 Q3	$167M	Sell	2,700,393 -133,077	-5%	-$8.46M	0.24%	91
2014 Q2	$181M	Buy	2,833,470 +22,986	+0.8%	+$1.4M	0.27%	84
2014 Q1	$173M	Sell	2,810,484 -538,451	-16%	-$31.4M	0.28%	73
2013 Q4	$192M	Buy	3,348,935 +556,261	+20%	+$31.5M	0.31%	66
2013 Q3	$149M	Buy	2,792,674 +384,316	+16%	+$20.7M	0.28%	74
2013 Q2	$124M	Buy	+2,408,358	New	+$119M	0.25%	81

Other funds holding MDT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock's MDT Position: Q1 2026 in Review

BlackRock reduced its Medtronic (MDT) stake by 6.1% in Q1 2026, selling an estimated $705M and leaving 113,182,567 shares worth $9.81B. The position accounts for 0.17% of the portfolio, ranked #97.

BlackRock first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $13B in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

BlackRock held 113,182,567 shares of Medtronic worth $9.81B as of Q1 2026.
BlackRock sold 7,355,311 Medtronic shares in Q1 2026, an estimated $705M.
Medtronic made up 0.17% of BlackRock's portfolio in Q1 2026, its #97 holding.
BlackRock first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
BlackRock's Medtronic position peaked at $13B in Q2 2021.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.